ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,070.40
0.00%
Dow Jones
40,003.59
0.34%
Brent Oil
84.005
0.49%
Bitcoin
66,800.28
0.97%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Aerovate Therapeutics Inc (AVTE) Quote

Aerovate Therapeutics Inc

Aerovate Therapeutics Inc (AVTE)

NASDAQ
20.57
0.00
(0.00%)
Closed May 20 4:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
20.57
Bid
8.16
Ask
32.56
Volume
-
0.00 Day's Range 0.00
9.41 52 Week Range 32.415
Market Cap
569.149M
Previous Close
20.57
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
161,365
Shares Outstanding
27,668,887
Dividend Yield
-
PE Ratio
-7.54
Earnings Per Share (EPS)
-2.73
Revenue
-
Net Profit
-75.52M

About Aerovate Therapeutics Inc

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hyper... Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.aerovatetx.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Aerovate Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AVTE. The last closing price for Aerovate Therapeutics was $20.57. Over the last year, Aerovate Therapeutics shares have traded in a share price range of $ 9.41 to $ 32.415.

Aerovate Therapeutics currently has 27,668,887 shares outstanding. The market capitalization of Aerovate Therapeutics is $569.15 million. Aerovate Therapeutics has a price to earnings ratio (PE ratio) of -7.54.

AVTE Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

May 17 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

May 17 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 13 2024
Edgar (US Regulatory)

Form 8-K - Current report

May 13 2024
Edgar (US Regulatory)

Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights

Topline data expected in June 2024 from Phase 2b portion of the IMPAHCT global Phase 2b/Phase 3 clinical trial of AV-101 for pulmonary arterial hypertension (PAH) Enrollment continues into the...

May 13 2024
GlobeNewswire Inc.

Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conference

WALTHAM, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that improve the lives of...

March 27 2024
GlobeNewswire Inc.

Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlights

Topline data expected in June 2024 from Phase 2b portion of the IMPAHCT global Phase 2b/Phase 3 clinical trial of AV-101 for pulmonary arterial hypertension (PAH) Completed enrollment in the...

March 25 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

March 11 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.783.9413845376519.7922.4818.3724003520.43341549CS
4-1.53-6.9230769230822.123.976418.3715319720.86847869CS
121.216.2519.3632.41518.0816136524.48476857CS
266.0841.959972394814.4932.41514.0912533522.26774347CS
521.9610.53197205818.6132.4159.4110289319.32285899CS
156-7.43-26.53571428572832.4157.7410016218.62860502CS
260-7.43-26.53571428572832.4157.7410016218.62860502CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.37
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 65.09
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.91
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.4599
(0.00%)
0
AACGATA Creativity Global
$ 0.91
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.37
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 65.09
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.91
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.4599
(0.00%)
0
AACGATA Creativity Global
$ 0.91
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.37
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 65.09
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.91
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.4599
(0.00%)
0
AACGATA Creativity Global
$ 0.91
(0.00%)
0

Discussion

View Full Feed
SkeBallLarry SkeBallLarry 4 minutes ago
Iran's President Raisi killed in helicopter crash >

https://edition.cnn.com/middleeast/live-news/raisi-iran-president-helicopter-crash-05-20-24/h_307c274d4c55fe72fe5bf43474d28ce3
pegs1 pegs1 5 minutes ago
Test Pilot 🧑‍✈️
That’s great news! Thanks for sharing this information! I still predict the closing will be June 1st!……,
CRTG
SkeBallLarry SkeBallLarry 5 minutes ago
Iran's President Raisi killed in helicopter crash >

https://edition.cnn.com/middleeast/live-news/raisi-iran-president-helicopter-crash-05-20-24/h_307c274d4c55fe72fe5bf43474d28ce3
SkeBallLarry SkeBallLarry 6 minutes ago
Iran's President Raisi killed in helicopter crash >

https://edition.cnn.com/middleeast/live-news/raisi-iran-president-helicopter-crash-05-20-24/h_307c274d4c55fe72fe5bf43474d28ce3
Seminole Red Seminole Red 6 minutes ago
Gotta watch those N.Y. bankers, most all are crooked
Xl175 Xl175 6 minutes ago
All those weeks of following hoping buying and what do you have? An expensive penny stock with a very limited market. But who knows maybe Joe gets up tomorrow and decides Louisiana is important and he wants to throw Texas a bone too…. Hay hay could happen. How many here believe in Santa Clause?
TGLO
SkeBallLarry SkeBallLarry 6 minutes ago
Iran's President Raisi killed in helicopter crash >

https://edition.cnn.com/middleeast/live-news/raisi-iran-president-helicopter-crash-05-20-24/h_307c274d4c55fe72fe5bf43474d28ce3
Wolf-man jack Wolf-man jack 11 minutes ago
Welcome back. I was thinking about YQU on Sunday. Had forgotten your handle. You were thinking about selling Imperial. If you are at liberty to say, how much would your company be worth. Ball park figure. How much do YQU think Elevated would be worth if it is possible to speculate from their website
CVSI
RichieBoy RichieBoy 17 minutes ago
We finally know why Contrivian and OneMindNG
really went dark on the hush hush project in SanFrancisco. Saving lives sounds like a good reason to go NDA if you ask me. This sounds to have been mostly if not all about NorthStar rather than Hypervisor though the article does talk about toll roa
AFFU
Xl175 Xl175 19 minutes ago
What is the path forward for securing the permit and license? Is Kamala going to have it as an agenda item? High priority? Once she is president I guess she will push hard for American energy.
TGLO
Ppastis Ppastis 19 minutes ago
You are speaking about ‘ disrespect ‘ ?? You … do you really mean this ??????

#theliar
#thejoker
LWLG
torontoasian torontoasian 19 minutes ago
Watchlist on stockwitts has increased over the weekend. More eyes on this 🔥

Let’s have a good week🫡
PLPL
powerbattles powerbattles 23 minutes ago
GWAV gets a lot of attention. 8-K out & should be cautious. Imho.
On May 10, 2024, the Company entered into an exchange agreement (the “Exchange Agreement”) with DWM Properties LLC (the “Holder”), whereby the Company and Holder agreed to exchange 1,000 shares of the Company’s Series D Prefer
BSFC FFIE GWAV
arachnodude arachnodude 26 minutes ago
LOL! Thanks for confirming. 🤪
KBLB
MagnetLover MagnetLover 26 minutes ago
The biggest assumption here is that the energy from light fixtures is worth collecting economically.

Assuming old fashioned bulbs : Why harvesting it with a black PV panel behind the bulb, diminishing the lighting output when one can use a cheap mirror to reflect it back to the room
FLCX
hawkshaw812 hawkshaw812 30 minutes ago
Pink sheet uneducated are welcome in my book the more the better
KULR
hawkshaw812 hawkshaw812 32 minutes ago
I agree he does but he needs to quit putting people down , investors have every right to be here just like he does peiord
KULR
leverage102 leverage102 34 minutes ago
NSAV $$$
NSAV in the last hour has 18,435 VIEWS AT 3:00 AM, last hour sits on top of most viewed.
International Marketing $$$$$$

Number 1 last hour: https://investorshub.advfn.com/boards/most_read.aspx?p=h

Number 4 overall.. https://investorshub.advfn.
NSAV
tnc26 tnc26 37 minutes ago
Is not into common shares but then where are these new 3 million shares came from?? Look like almost every 6 months or si ab additional shares being added to the outstanding shares. Maybe u could ask tge management that questions.. This stuff can spook the investors..I just don't know what will tak
DFCO
Seekingthelight Seekingthelight 42 minutes ago
$25 plus for tomorrow!!! Hoping
GME
moondogaz moondogaz 44 minutes ago
All you got to do is Google chicken paws china...." They are in such demand that they are often more expensive than chicken meat" you can make fun..that's cool... But the shiz is gonna pop...
SPZI
Love Boat Captain Love Boat Captain 45 minutes ago
NICE appraisal page for NWBO is down. https://x.com/peter_brit/status/1792441297980076337?s=46&t=eKWlfJ_s47ckE6GTsb7D0w
NWBO
KeyKey KeyKey 52 minutes ago
Yes, and when LIBOR is closed and still no money will appear, then we finally can close this "further distributions" hope completely.
But who can explain to me the correlation between LIBOR and SAFE HARBOR ? Why does "opening" safe harbor has to wait till closure of libor ? Is this really lo
COOP

Your Recent History

NASDAQ
AVTE
Aerovate Therapeutics
NASDAQ
ADEAV
Adeia
NASDAQ
AFREZ
America First Real Estate
NASDAQ
ALLSB
Allstream
NASDAQ
MNLO
Menlo Therapeutics
NASDAQ
ARTAU
Artisan Acquisition
NASDAQ
AIP
Arteris
TG
APCX
Apple
NASDAQ
MTC
MMTec
TSXV
AEP
Atlas Engineered Products
NASDAQ
YNDX
Yandex NV
NASDAQ
MTEC
NASDAQ
AINV
Apollo Investment
NASDAQ
ALTA
AltaBancorp
AMEX
ZZZ
Test
NASDAQ
CRTD
Creatd
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved